Early interventions have the greatest impact.

Yet most children with developmental conditions aren’t even diagnosed until after 4 years old. Many underserved children are missed altogether.

We make life-changing early diagnosis and interventions possible with breakthrough innovations that save time, optimize resources, and positively impact the lives of children and families.

canvas dx logo

Act early on developmental concern

 

Early, Rapid, Equitable Diagnosis of Autism

Canvas Dx is the first and only FDA authorized diagnostic solution designed to equip healthcare providers to diagnose or rule out autism in children ages 1.5 to 6 years – within days, not months or years. 

Remote, digital evaluation of children with developmental concerns overcomes long distances to scarce, oversubscribed specialty centers

Faster path to next steps for all children – with and without autism, and those needing further evaluation 

Objective, data-driven approach alleviates prevalent biases in diagnoses 

Why it matters

The status quo for diagnosis is slow, complicated, and expensive. Delays stack up, while children are missing out on timely care.
Read more about the waitlist crisis.

3 year delay in diagnosis

hourglass icon

Autism can be reliably diagnosed as early as age 18 months. Most children are only diagnosed after age 4.

Costly delays

cost icon

Late diagnosis costs the healthcare system 2.5x than a shorter path to diagnosis.

Inequities

inequities icon

Girls are diagnosed 1.5 years later than boys. Underserved, minority children are often missed altogether.

Data changes lives.

Medicine is in an era of intelligent technology, but there have been almost no advancements in child developmental health. We are determined to change that. 

With our whole-child approach and responsible AI, we fortify the diagnosis of developmental concerns at the earliest and most opportune times. Our approach delivers an informed, rapid, and universally accessible path to care that saves precious time and gives children and their families the power of knowledge and the ability to realize their most fulfilling lives. 



Technology

Get the latest updates from Cognoa. Join our mailing list:

How AI Innovation Can Break Down Barriers in the Crisis of Late Diagnosis of Autism in Children

Cognoa’s FDA-approved autism diagnostic tool now in-network for Highmark members

Shining a spotlight on children’s health with Cognoa

Unlocking Equitable Pediatric Care with Dr. Sharief Taraman